Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enfusion (ENFN)
NYSE:ENFN
Holding ENFN?
Track your performance easily
ENFN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$7.52 - $10.45
Previous Close$9.05
Volume1.08M
Average Volume (3M)358.96K
Market Cap
$1.16B
Enterprise Value$1.17B
Total Cash (Recent Filing)$34.45M
Total Debt (Recent Filing)$18.00M
Price to Earnings (P/E)306.8
Beta0.80
Next Earnings
Nov 04, 2024EPS Estimate
$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding128,409,499
10 Day Avg. Volume252,830
30 Day Avg. Volume358,963
Standard Deviation0.16
R-Squared0.08
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)18.10
Price to Sales (P/S)6.17
Price to Cash Flow (P/CF)39.70
P/FCF Ratio46.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.22
Enterprise Value/Gross Profit10.02
Enterprise Value/Ebitda44.98
Forecast
1Y Price Target
$9.50Price Target Upside8.94% Upside
Rating ConsensusHold
Number of Analyst Covering5
Enfusion News
PremiumCompany Announcements
Enfusion, Inc. Reports Strong Q3 2024 Results
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement reiterates its full-year guidance calling for nearly 18% revenue growth and 21% adjusted EBITDA margin, highlighting continued margin expansion and growth momentum expected throughout the remainder of the year.
Market OpportunityThe company’s steady combination of high growth and profitability in a largely underpenetrated market opportunity.
Product DevelopmentA meaningful acceleration in product velocity (which is already showing signs of incremental backlog / ACV uplift for newer products like Portfolio Workbench).
Bears Say
Client GrowthNet new clients were only +3 (33 new less 30 churned), and commentary on higher churn and downgrades could raise concerns.
CompetitionRisks to consider include competition among large, well-capitalized vendors, pace of asset management cloud adoption, and execution risk.
Earnings Guidance2024 revenue guidance of $200-210mn was only reiterated, implying a growth range of 14.6-20.3%.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ENFN FAQ
What was Enfusion’s price range in the past 12 months?
Enfusion lowest stock price was $7.52 and its highest was $10.45 in the past 12 months.
What is Enfusion’s market cap?
Currently, no data Available
When is Enfusion’s upcoming earnings report date?
Enfusion’s upcoming earnings report date is Nov 04, 2024 which is yesterday.
How were Enfusion’s earnings last quarter?
Enfusion released its earnings results on Aug 06, 2024. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.056 by -$0.006.
Is Enfusion overvalued?
According to Wall Street analysts Enfusion’s price is currently Undervalued.
Does Enfusion pay dividends?
Enfusion does not currently pay dividends.
What is Enfusion’s EPS estimate?
Enfusion’s EPS estimate is $0.06.
How many shares outstanding does Enfusion have?
Enfusion has 93,210,730 shares outstanding.
What happened to Enfusion’s price movement after its last earnings report?
Enfusion reported an EPS of $0.05 in its last earnings report, missing expectations of $0.056. Following the earnings report the stock price went down -7.861%.
Which hedge fund is a major shareholder of Enfusion?
Among the largest hedge funds holding Enfusion’s share is Royce & Associates LLC. It holds Enfusion’s shares valued at 628K.
---
Enfusion Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.50 (8.94% Upside)
$9.50 (8.94% Upside)
Blogger Sentiment
Bullish
ENFN Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 73.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $32.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.99%
12-Months-Change
Fundamentals
Return on Equity
6.68%
Trailing 12-Months
Asset Growth
27.68%
Trailing 12-Months
Company Description
Enfusion
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute better-informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth.
---
ENFN Earnings Call
Q2 2024
0:00 / 0:00
---
ENFN Stock 12 Month Forecast
Average Price Target
$9.50
▲(8.94% Upside)
Technical Analysis
Best Analysts Covering ENFN
1 Year
1 Year Success Rate
4/6 ratings generated profit
1 Year Average Return
-0.82%
reiterated a sell rating 6 months ago
Copying Koji Ikeda's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -0.82% per trade.
---